|
|
|
| Association between Neutrophil to Lymphocyte Ratio and All-Cause Mortality in Elderly Patients with Cardiovascular Disease |
| YANG Yapan, XU Gui'an, ZHU Lijie, YANG Yanjie, WANG Che, LI Qingman, YANG Honghui |
| Fuwai Central China Cardiovascular Hospital, Zhengzhou Henan 450000 |
|
|
|
|
Abstract 【Objective】 To investigate the relationship between neutrophil to lymphocyte ratio (NLR) and all-cause mortality in elderly patients with cardiovascular disease (CVD). 【Methods】 A total of 3206 elderly patients with CVD were included from the National Health and Nutrition Examination Survey of America from 1999 to 2018. The participants were divided into four groups according to the quartiles of NLR: Q1 (NLR<1.74), Q2 (1.74≤NLR< 2.37), Q3 (2.37≤NLR < 3.23), and Q4 (NLR≥3.23). The association between NLR and all-cause mortality was analyzed, and the predictive value of NLR for all-cause mortality was evaluated. 【Results】 The Kaplan-Meier survival analysis showed that the higher NLR level group had a lower survival rate. The Cox proportional hazards regression model showed that after adjusting for confounding factors, there is a significant positive association between elevated NLR levels and the risk of all-cause mortality. Compared with the lowest NLR level group Q1, the highest NLR level group Q4 had a 45% increased risk of all-cause mortality (P<0.05). Restricted cubic spline analysis showed a non-linear positive correlation between NLR and all-cause mortality risk (P<0.05). The time-dependent receiver operating characteristic (ROC) curve analysis showed that the area under the curve for predicting all-cause mortality in elderly CVD patients using NLR at 1, 3, 5, and 10 years were 0.649, 0.625, 0.617, and 0.597, respectively. 【Conclusion】 Elevated NLR levels are independently associated with increasing all-cause mortality in elderly patients with cardiovascular disease, which helps identify high-risk individuals in this population.
|
|
Received: 28 November 2025
|
|
|
|
|
|
[1] Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023[J].J Am Coll Cardiol,2025, 86(22):2167-2243. [2] 王增武. 《中国心血管健康与疾病报告2024》:心血管疾病及其危险因素流行状况[J].中国心血管病研究,2025,23(9):771-793. [3] RURIK J G, AGHAJANIAN H, EPSTEIN J A. Immune cells and immunotherapy for cardiac injury and repair[J].Circ Res,2021, 128(11):1766-1779. [4] SARRAFAN-CHAHARSOUGHI Z, SINAII N, DEMIDOWICH A P, et al. The association of neutrophil-to-lymphocyte ratio with metabolic syndrome in U.S. adults:findings from the 1999-2018 National Health and Nutrition Examination survey[J].J Clin Transl Endocrinol,2025, 39:100382. [5] ZHANG X Y, LI D Y, DU Y W. Prognostic value of the neutrophil to lymphocyte ratio for cardiovascular diseases: Research progress[J].Am J Transl Res,2025, 17(2):1170-1177. [6] GUO J H, WANG D D, JIA J K, et al. Neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio as predictors of short- and long-term outcomes in ischemic stroke patients with atrial fibrillation[J].J Inflamm Res,2024, 17:6661-6672. [7] LEE G K, LEE L C, CHONG E, et al. The long-term predictive value of the neutrophil-to-lymphocyte ratio in type 2 diabetic patients presenting with acute myocardial infarction[J].QJM,2012, 105(11):1075-1082. [8] TIAN H N, JIANG X T, DUAN G Y, et al. Preoperative inflammatory markers predict postoperative clinical outcomes in patients undergoing heart valve surgery: a large-sample retrospective study[J].Front Immunol,2023, 14:1159089. [9] DING B, LIU P F, ZHANG F F, et al. Predicting values of neutrophil-to-lymphocyte ratio(NLR), high-sensitivity c-reactive protein(hs-CRP), and left atrial diameter(LAD) in patients with nonvalvular atrial fibrillation recurrence after radiofrequency ablation[J].Med Sci Monit,2022, 28:e934569. [10] REZIG A O M, MORSY M I, CAIAZZO E, et al. Neutrophil-to-lymphocyte ratio: Link to congestion, inflammation, and mortality in outpatients with heart failure[J].ESC Heart Fail,2025, 12(3):1571-1582. [11] LUO J, THOMASSEN J Q, NORDESTGAARD B G, et al. Neutrophil counts and cardiovascular disease[J].Eur Heart J,2023, 44(47):4953-4964. [12] YAVUZ B B, YAVUZ B, SENER D D, et al. Advanced age is associated with endothelial dysfunction in healthy elderly subjects[J].Gerontology,2008, 54(3):153-156. [13] WARNY M, HELBY J, NORDESTGAARD BG, et al. Incidental lymphopenia and mortality: A prospective cohort study[J].CMAJ,2020, 192(2):E25-E33. [14] LIU Z Q, LIANG Q M, REN Y Q, et al. Immunosenescence: Molecular mechanisms and diseases[J].Signal Transduct Target Ther,2023, 8(1):200. [15] KOJTA I, CHACIЍSKA M, BŁACHNIO-ZABIELSKA A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance[J].Nutrients,2020, 12(5):1305. |
|
|
|